NA

Nabh Agrawal

Active Director Director DIN 10736888
DIN 10736888 First appointment Aug 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Aug 2024
Shareholding value •••• Premium profile

About Nabh Agrawal

Data last updated:

Nabh Agrawal is a Director at Theta Pharmaceuticals Limited (since 2024). The company operates in Pharma. Theta Pharmaceuticals Limited reported revenue of ₹5.18 Cr (FY 2025).

DIN 10736888
Primary Designation Director
Industry Pharma
First Appointment 09 Aug 2024
Oldest Company Age 24 yrs
Largest company Theta Pharmaceuticals Limited · ₹5.18 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Theta Pharmaceuticals Limited U51397MH2002PLC136652
Director09 Aug 20242002₹5.18 Cr (FY 2025)Active

Board colleagues of Nabh Agrawal

Directorship timeline

Open interactive timeline →
Theta Pharmaceuticals Limited
Premium access

Shareholding and investment profile for Nabh Agrawal

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Nabh Agrawal

Nabh Agrawal currently holds 1 directorship: Theta Pharmaceuticals Limited (Director, since 09 Aug 2024, revenue ₹5.18 Cr (FY 2025)).

Nabh Agrawal was first appointed on 09 Aug 2024 as Director at Theta Pharmaceuticals Limited.

The current boards of Nabh Agrawal's companies include Bharat Agrawal (Theta Pharmaceuticals Limited), Meena Agrawal (Theta Pharmaceuticals Limited), Shyam Gupta (Theta Pharmaceuticals Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available